Auryxia (Keryx Biopharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Auryxia drug offered from Keryx Biopharmaceuticals, Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Keryx Biopharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | ferric citrate |
| SUBSTANCE NAME: | TETRAFERRIC TRICITRATE DECAHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-17 |
| END MARKETING DATE: | 0000-00-00 |
Auryxia HUMAN PRESCRIPTION DRUG Details:
| Item Description | Auryxia from Keryx Biopharmaceuticals, Inc. |
| LABELER NAME: | Keryx Biopharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 210(mg/1) |
| START MARKETING DATE: | 2014-09-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59922-631_fec0ab98-d8ba-45c2-9017-ca1407116872 |
| PRODUCT NDC: | 59922-631 |
| APPLICATION NUMBER: | NDA205874 |
Other TETRAFERRIC TRICITRATE DECAHYDRATE Pharmaceutical Manufacturers / Labelers:
